These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1189 related articles for article (PubMed ID: 19801494)

  • 81. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
    Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
    Karpanen T; Bry M; Ollila HM; Seppänen-Laakso T; Liimatta E; Leskinen H; Kivelä R; Helkamaa T; Merentie M; Jeltsch M; Paavonen K; Andersson LC; Mervaala E; Hassinen IE; Ylä-Herttuala S; Oresic M; Alitalo K
    Circ Res; 2008 Oct; 103(9):1018-26. PubMed ID: 18757827
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 84. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
    Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
    Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer.
    Sakata S; Lebeche D; Sakata Y; Sakata N; Chemaly ER; Liang LF; Padmanabhan P; Konishi N; Takaki M; del Monte F; Hajjar RJ
    Mol Ther; 2006 May; 13(5):987-96. PubMed ID: 16503203
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Systo-diastolic ventricular function in patients with hypertension: an echocardiographic tissue doppler imaging evaluation study.
    Leggio M; Sgorbini L; Pugliese M; Mazza A; Bendini MG; Fera MS; Giovannini E; Leggio F
    Int J Cardiovasc Imaging; 2007 Apr; 23(2):177-84. PubMed ID: 16972147
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse.
    Reed AL; Tanaka A; Sorescu D; Liu H; Jeong EM; Sturdy M; Walp ER; Dudley SC; Sutliff RL
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H824-31. PubMed ID: 21724869
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
    Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion.
    Choi YS; de Mattos AB; Shao D; Li T; Nabben M; Kim M; Wang W; Tian R; Kolwicz SC
    J Mol Cell Cardiol; 2016 Nov; 100():64-71. PubMed ID: 27693463
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
    De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy.
    Flesch M; Schiffer F; Zolk O; Pinto Y; Stasch JP; Knorr A; Ettelbrück S; Böhm M
    J Hypertens; 1997 Sep; 15(9):1001-9. PubMed ID: 9321748
    [TBL] [Abstract][Full Text] [Related]  

  • 92. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4.
    Mori J; Alrob OA; Wagg CS; Harris RA; Lopaschuk GD; Oudit GY
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1103-13. PubMed ID: 23396452
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Can ambulatory blood pressure monitoring detect early diastolic dysfunction in children with type 1 diabetes mellitus: correlations with B-type natriuretic peptide and tissue Doppler findings.
    Kır M; Cetin B; Demir K; Yılmaz N; Kızılca O; Demircan T; Unal N; Bober E; Saylam GS
    Pediatr Diabetes; 2016 Feb; 17(1):21-7. PubMed ID: 25384349
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pressure Overload Creates Right Ventricular Diastolic Dysfunction in a Mouse Model: Assessment by Echocardiography.
    Egemnazarov B; Schmidt A; Crnkovic S; Sydykov A; Nagy BM; Kovacs G; Weissmann N; Olschewski H; Olschewski A; Kwapiszewska G; Marsh LM
    J Am Soc Echocardiogr; 2015 Jul; 28(7):828-43. PubMed ID: 25840639
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression.
    Røe ÅT; Ruud M; Espe EK; Manfra O; Longobardi S; Aronsen JM; Nordén ES; Husebye T; Kolstad TRS; Cataliotti A; Christensen G; Sejersted OM; Niederer SA; Andersen GØ; Sjaastad I; Louch WE
    Cardiovasc Res; 2019 Mar; 115(4):752-764. PubMed ID: 30351410
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus.
    Scognamiglio R; Avogaro A; Casara D; Crepaldi C; Marin M; Palisi M; Mingardi R; Erle G; Fasoli G; Dalla Volta S
    J Am Coll Cardiol; 1998 Feb; 31(2):404-12. PubMed ID: 9462586
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart.
    Matesic LE; Freeburg LA; Snyder LB; Duncan LA; Moore A; Perreault PE; Zellars KN; Goldsmith EC; Spinale FG
    Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H765-H774. PubMed ID: 32822210
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.
    Chen WJY; Diamant M; de Boer K; Harms HJ; Robbers LFHJ; van Rossum AC; Kramer MHH; Lammertsma AA; Knaapen P
    Cardiovasc Diabetol; 2017 May; 16(1):67. PubMed ID: 28526033
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Role of Mitochondrial Oxidative Stress in Glucose Tolerance, Insulin Resistance, and Cardiac Diastolic Dysfunction.
    Jeong EM; Chung J; Liu H; Go Y; Gladstein S; Farzaneh-Far A; Lewandowski ED; Dudley SC
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27151515
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca
    Law ML; Prins KW; Olander ME; Metzger JM
    Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1544-H1552. PubMed ID: 30118340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.